VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,917,015 | -0.8% | 71,238 | +11.1% | 0.18% | +0.6% |
| Q2 2023 | $1,931,527 | +79.2% | 64,149 | +92.5% | 0.17% | +91.2% |
| Q1 2023 | $1,078,064 | +115.3% | 33,325 | +90.7% | 0.09% | +89.6% |
| Q4 2022 | $500,834 | +72.1% | 17,475 | +44.7% | 0.05% | +37.1% |
| Q3 2022 | $291,000 | +7.8% | 12,075 | +71.5% | 0.04% | +25.0% |
| Q1 2022 | $270,000 | +13400.0% | 7,040 | +6940.0% | 0.03% | – |
| Q3 2018 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | -60.0% | 100 | -50.0% | 0.00% | -100.0% |
| Q3 2017 | $5,000 | +150.0% | 200 | +100.0% | 0.00% | 0.0% |
| Q2 2017 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |